Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008242 Administering 1-3,4-trans-2,2-dimethy-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)etho xy)phenyl)-7-methoxychroman
12/28/1999US6008241 A photodynamic therapy
12/28/1999US6008233 (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
12/28/1999US6008232 Methods for preventing headaches
12/28/1999US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999US6008228 Comprising a mixture of carrier monoglycerides of medium chain-fatty acids
12/28/1999US6008227 Process for blocking 5-HT and dopamine uptake with biologically active tropane derivatives
12/28/1999US6008226 Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
12/28/1999US6008225 Derivatives of antibiotic GE2270 factors C2a, D2 and E
12/28/1999US6008222 Increasing bioavailability of buspirone and eliminating metabolite formation
12/28/1999US6008221 Method for treating Alzheimer's disease with folic acid
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008219 Bicyclic amine derivatives and their use as anti-psychotic agents
12/28/1999US6008216 Process for preparing 2-methyl-thieno-benzodiazepine
12/28/1999US6008215 Benzonaphthyridines as bronchial therapeutics
12/28/1999US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/28/1999US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin
12/28/1999US6008210 Administering epoxymexrenone
12/28/1999US6008209 Method of using vitamin D3 analogs with bis C-20 side chains
12/28/1999US6008208 Administering oxygen and/or nitrogen and/or sulfur-containing fused, aromatic compound linked, aromatic compound
12/28/1999US6008207 Anhydrous alendronate monosodium salt formulations
12/28/1999US6008206 Sodium alendronate preparation for local administration
12/28/1999US6008204 Antidotes for preventing certain undesired side effects of retinoids
12/28/1999US6008203 Administering a sialylated lactose carbohydrate compound antitumor agent
12/28/1999US6008198 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
12/28/1999US6008190 Cobalt Schiff base compounds
12/28/1999US6008188 Cytokine potentiator and pharmaceutical formulation for cytokine administration
12/28/1999US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/28/1999US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999US6008017 Human cardiac/brain tolloid-like protein
12/28/1999US6008015 Glycine transporter
12/28/1999US6007986 Methods for anti-addictive narcotic analgesic activity screening
12/28/1999US6007865 For inhibiting and reversing nonenzymatic cross-linking (protein aging), treating kidney damage and treating complications of diabetes, preventing food spoilage
12/28/1999US6007843 Storage stable, sterile, pure mixture comprising active drug dispersed within polysaccharide matrix comprising blend of hyaluronic acid or salt and a nonionic polysaccharide where matrix is dissolved or suspended in liquid medium
12/28/1999US6007841 Effective narcotic agonist-antagonist analgesic potentiated by concurrently administered nontoxic n-methyl-d-aspartate receptor antagonist
12/28/1999US6007834 Nasal melatonin composition
12/28/1999US6007831 Increasing concentration of water soluble surfactant/soap in soap bar mixture or associating soap with a more water soluble counterion to provide a zein dissolution ratio of greater than 1
12/28/1999US6007829 Topically applied mixture comprising a carrier and water soluble compound(s) of free acid or salt of ethylene glycol disuccinic acid, 2,2'-oxydisuccinic acid and/or sulfosuccinic acid to increase collagen synthesis in skin cells
12/28/1999US6007827 Method of depigmenting or bleaching mammalian skin using L-2-oxothiazolidine-4-carboxylic acid
12/28/1999US6007824 Orally administering synergistic mixture of l-arginine, ginseng and zizyphi fructus to stimulate release of nitrogen monoxide and cause smooth muscle relaxation in human body
12/28/1999US6007823 Simmondsin concentrate from jojoba
12/28/1999US6007822 Immunogenic plant extract mixed into animal feed; bactericides, viricides, free radical scavengers, antioxidants
12/28/1999US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines
12/28/1999US6007808 Nutrient mixture of eubiotic bacteria and glutamine or glutamine-containing polypeptide
12/28/1999US6007803 Administering to mammal a cationic polymer to inhibit pathogenic toxins
12/28/1999US6007796 Cosmetic self-tanning agent having a sunscreen effect
12/28/1999US6007795 Compositions including particles including degradable material and anti-microbial agent
12/28/1999US6007774 Administering a biocompatible non-blood oxygen carrier while monitoring one or more oxygenation indices to maintain oxygenation of the patient's tissues at or above a predetermined level
12/28/1999US6006752 Mixed chimerism and tolerance
12/28/1999CA2177683C Tissue moisturizing and antimicrobial compositions
12/28/1999CA2156623C Skin care composition
12/28/1999CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments
12/28/1999CA2131769C Novel cephalosporin antibiotics and processes for preparation thereof
12/28/1999CA2118171C Galanthamine derivatives, a process for their preparation and their use as medicaments
12/28/1999CA2099473C Depigmenting cosmetic and/or dermatologic composition containing a di- or tri-cafeoylquinic acid or a blend of these acids
12/28/1999CA2037150C Retinoids
12/28/1999CA2013087C Carbonate derivatives of eseroline, a process for their preparation and their use as medicaments
12/28/1999CA2009687C Organosiloxane-containing polysaccharides
12/28/1999CA2005990C Antiretroviral aryloxy substituted furan ketones
12/28/1999CA2001715C Carbocyclic nucleosides and nucleotides
12/28/1999CA1340861C Cysteine-depleted muteins of biologically active proteins
12/24/1999CA2241647A1 Transitional metal complexes of non steroidal anti-inflammatory drugs
12/23/1999WO1999066072A2 Methods for treating a neurological disease by determining bche genotype
12/23/1999WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065930A1 Vitamin b12 derivatives and methods for their preparation
12/23/1999WO1999065922A2 Prenyl transferase inhibitors
12/23/1999WO1999065920A1 Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
12/23/1999WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999WO1999065915A1 Polymorphic clopidogrel hydrogenesulphate form
12/23/1999WO1999065914A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
12/23/1999WO1999065912A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
12/23/1999WO1999065910A1 Fused azepinone cyclin dependent kinase inhibitors
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065907A1 Triazolo-pyrimidines as ligands for gaba receptors
12/23/1999WO1999065906A1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
12/23/1999WO1999065904A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999WO1999065900A1 Chemical synthesis of morpholine derivatives
12/23/1999WO1999065898A1 Imidazolyl derivatives
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
12/23/1999WO1999065894A1 Macrocyclic analogs and methods of their use and preparation
12/23/1999WO1999065893A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065876A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999WO1999065875A1 Telomerase inhibitors
12/23/1999WO1999065874A1 Benzanilide derivatives and medicinal compositions
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065871A2 Thiolesters and uses thereof
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065866A1 Anthracene derivatives as anti-cancer agents